Researchers Link CACNA1C Variants to Focal Epilepsy
A new study identifies three de novo gene variants associated with focal epilepsy in patients.
Updated on Oct. 23, 2026 in Alzheimer’s
Scientists have identified three de novo CACNA1C variants in patients diagnosed with focal epilepsy. These findings expand the understanding of how this specific gene contributes to neurological conditions beyond its previously established role in arrhythmias.
Why it matters
Understanding the genetic drivers of epilepsy is critical for improving diagnostic accuracy and tailoring medical care for patients. This research highlights the complex role CACNA1C plays in neurological and developmental health.
Researchers identified three variants with no minor allele frequency in the Genome Aggregation Database, alongside existing data on 138 arrhythmia-linked and 30 developmental disorder-linked CACNA1C variants. These findings were evaluated using standard ACMG criteria.
The details
Using trio-based whole-exome sequencing, researchers classified these three variants as pathogenic or likely pathogenic. While two patients achieved seizure freedom, one patient with the variant presented with refractory epilepsy, developmental disorders, and arrhythmia.
The Big Picture
This study utilizes the American College of Medical Genetics and Genomics classification to validate the clinical significance of the newly discovered variants. It extends current scientific knowledge by mapping CACNA1C mutations to epilepsy, following established precedents set by previous arrhythmia and developmental disorder research.
These findings provide a path for patients with unexplained focal epilepsy to undergo more targeted genetic screening. Confirming a pathogenic variant can help clinicians anticipate potential comorbidities like arrhythmia and adjust treatment plans accordingly.
The takeaway
Genetic screening is becoming an essential tool for identifying the root causes of complex neurological conditions like epilepsy. Patients should consult with a specialist to discuss whether genetic testing is appropriate based on their specific clinical presentation.
Further reading
Learn more about ongoing neurological research in our Alzheimer’s section.
Source note: This article includes information reported by Journal of Medical Genetics.
